Integral Derivatives’s Cavium, Inc. CAVM Stock Holding History

Integral Derivatives’s Portfolio CAVM Stock Details CAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,000	Closed	-$307K	–	1325
2015 Q3	$307K	Buy	+5,000	New	+$333K	0.01%	853

Other funds holding CAVM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Integral Derivatives's CAVM Position: Q3 2017 in Review

Integral Derivatives sold out of Cavium, Inc. (CAVM) in Q3 2017, closing a stake of 7,643 shares — an estimated $484K sold.

Integral Derivatives first reported a position in CAVM in Q4 2013 and held it in 2 quarters. The position peaked at $475K in Q2 2017. 232 funds tracked by Wall St. Rank hold CAVM as of Q3 2017.

Integral Derivatives reported no remaining Cavium, Inc. position as of Q3 2017 after selling out during the quarter.
Integral Derivatives sold 7,643 Cavium, Inc. shares in Q3 2017, an estimated $484K.
Integral Derivatives first reported a position in Cavium, Inc. in Q4 2013 and held it in 2 quarters.
Integral Derivatives's Cavium, Inc. position peaked at $475K in Q2 2017.
232 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2017.

Based on Integral Derivatives's 13F filing for Q3 2017, filed 14 Nov 2017.